Science

Rejuvenating Public Sector Science

How politicians view scienceDo federal scientists fear for their jobs for speaking the truth? What about corporate-funded science? Increasingly, powerful institutions have tried to curb scientific independence and integrity regarding issues as wide-ranging as public health, the environment, the economy, and government energy policy.

No

The Secret of Marlboro's Success: Freebase Nicotine

Cigarettes tied together with stringMost American cigarette makers, including Philip Morris (PM), have used ammonia in their manufacturing processes for decades, to "puff up" tobacco to increase its volume, highlight certain flavors, help hold together reconstituted tobacco sheet and reduce the amount of

No

Mixed Reports on FDA Efficacy

The number of warning letters sent by the U.S. Food and Drug Administration to corporations has dropped by 50% in the last decade. In 2002, the regulatory agency decided that all warning letters should go through the office of its chief counsel, a move "designed to strengthen the letters and make them legally consistent and credible." But the change may have just succeeded in slowing the process to a crawl.

No

Most Med Schools Not Making the Grade

The American Medical Students' Association (AMSA) graded 150 medical schools on their conflict-of-interest policies and the influence that drug companies have with faculty and students. Only seven of the schools surveyed received an "A"; 60 got a failing grade, for not having sufficient policies or for not participating in the survey. AMSA president Dr. Brian Hurley called strong conflict-of-interest policies "incredibly important to protect the educational experience." Dr.

No

Shifting Focus, Anti-Abortion Groups Oppose Contraception

On June 7, the anti-abortion groups American Life League (ALL) and Pharmacists for Life launched a new national campaign called "Protest the Pill Day 08: The Pill Kills Babies." Their goal is to convince American women to stop using oral contraceptives, which they believe kill people.

No

Thanks to Chantix, Quitting Smoking May Be Hazardous, Too

antismoking drug ChantixThe pharmaceutical company Pfizer "is preparing an advertising and public-relations campaign to counter concerns about its antismoking drug Chantix, once trumpeted as a potential billion-dollar-a-year blockbuster." So far, Pfizer has "run ads in five major newspapers in which its medical director explains Chantix's risk-benefit balance." The drug company will soon "start hosting rou

No

Pages

Subscribe to Science